A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery
Clinical trial NCT01539642 · COMPLETED
Trial details
- NCT number
- NCT01539642
- Sponsor
- Talphera, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2013-01-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.